Error loading player: No playable sources found
127304
CGTP Fall Virtual Summit 2024 Closing Remarks
Date
November 19, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Summit Chair: JR Dobbins, Eli Lilly and Company
Session Chair
General
Related Products
Session II - Development and Manufacturing Strategies Enabling the Commercialization of AAV Therapies & Session II: Panel Discussion - Questions & Answers
Session Chairs: JR Dobbins, _Eli Lilly and Company_, Darius Pillsbury, _ValSource Inc_., and Jennifer Wellman, _Akouos, Inc…
CASSS Welcome & CGTP Fall Virtual Summit 2024 Introduction
Summit Chair: JR Dobbins, Eli Lilly and Company
Session I - Mastering the Art of Control: CQAs and Considerations for Control Strategies for AAV-based Therapeutics & Session I - Panel Discussion - Questions & Answers
CQAs are essential attributes that must be monitored and controlled to ensure product quality. Understanding and defining CQAs has been challenging in the relatively new field of gene therapy, but is crucial to ensure patient safety and to meet regulatory standards…
